fibronectins on the surface of cultured fibroblasts and in extraceilular matrix fibrils were colocalized by fluorescent and high voltage immunoelectron microscopy. Fibroblast cultures grown in the presence or absence of cycloheximide were incubated with exogenous plasma fibronectin labeled with fluorescein isothiocyanate. A monoclonal antibody specific for the EIIIA sequence of cellular fibronectin was used to detect cellular fibronectin. A rabbit antifluorescein antibody identified fluoresceinated plasma fibronectin. In cultures incubated in the presence of cycloheximide, plasma fibronectin was bound to the cell surface and was assembled into extracellular fibrils. In cultures grown in the absence of cycloheximide, plasma and cellular fibronectins were observed in the same matrix fibrils and in the same locations on the cell surface. There was not, however, random admixture of the two proteins.
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F
IBRON ECTIN is a multifunctional glycoprotein that can be found in a fibrillar network in the extracellular matrix of connective tissues, basement membranes and cultured cells. There are at least 20 different forms of fibronectin that can be generated by alternative mRNA splicing of nascent mRNA (Schwarzbauer et al., 1983 (Schwarzbauer et al., , 1987a Kornblihtt et al., 1984 Kornblihtt et al., , 1985 . Plasma fibronectin (pFN) ~ differs from cellular fibronectin (cFN) in that it is missing completely two type III sequences (EDIIIA and EDIIIB) found in a portion of cFN subunits (Gutman and Kornblihtt, 1987; Schwarzbauer et al., 1987a; Zardi et al., 1987) . Both pFN and cFN can be found in tissues and in extracellular matrix fibrils of fibroblasts cultured in serum (Hayman and Ruoslahti, 1979; Oh et al., 1981) .
The incorporation of fibronectin into fibrils occurs principally at the cell surface (McKeown-Longo and Mosher, 1983) and requires the amino terminal portion of the molecule (McKeown-Longo and Mosher, 1985; McDonald et al., 1987; Schwarzbauer et al., 1987b; Quade and McDonald, 1988) and the cell adhesion domain (McDonald et al., 1987; Roman et al., 1989) . Both labeled pFN and cFN bind to the cell layer in two fractions, a deoxycholate-soluble fraction (cell surface fraction) and a deoxycholate-insoluble (extracellular matrix) fraction containing disulfide bonded fibronectin (McKeown-Longo and Mosher, 1983 Allio and McKeown-Longo, 1988) . Pulse chase experiments indicate that fibronectin binds initially in the deoxycholate soluble fraction and is transferred to the deoxycholate insoluble fraction (McKeown-Longo and Mosher, 1983; Barry and Mosher, 1989) . Binding and transfer can be downreg-ulated with cholera toxin (Allen-Hotfraann and and upregulated with transforming growth tactor-beta (Allen-Hoffmann et al., 1988) or, in HTI080 tumor cells, with dexamethasone (McKeown-Longo and Etzler, 1987) . Immunoelectron microscopy studies indicate that the aminoterminal fragment of fibronectin binds to the cell surface of fibroblasts like the intact molecule, but does not colocalize with fragments of fibronectin containing the cell adhesion sites (Peters and Mosher, 1987) . Assembly of fibronectin fibrils therefore appears to occur at sites that are distinct from or more complex than the cell attachment receptor (Pierschbacher et al., 1983; Pytela et al., 1985; Ruoslahti and Pierschbacher, 1987) . Soluble fibronectin, however, seems to interact with itself during formation of the fibronectin fibrils and can bind directly to matrix (Chernousov et al., 1985; Barry and Mosher, 1989) .
In this paper, we examined the binding and incorporation of exogenous pFN and endogenous cFN in human skin fibroblast cultures using fluorescent and immunoelectnan microscopy. In the fluorescent microscopy studies, fibroblast ~|-tures were incubated with pFN labeled with FITC and then labeled with a monoclonal antibody specific for the EIIIA sequence found in cFN (Borsi et al., 1987) . The antibody specific for cFN was localized using a rhodamine-conjugated goat anti-mouse IgG Electron microscopy studies used a goat anti-rabbit lgG bound to 18-rim gold beads to detect rabbit antifluorescein antibodies reacting with FITC-pFN. A goat anti-mouse IgG coupled to 5-nm gold beads localized the monoclonal antibody specific for EIIIA in the electron microscopy studies. These studies show that exogenously added pFN binds to regions of the cell surface where cFN is also localized, but does not need to bind to cFN to enter the matrix. In addition, these studies show that in a fibronec-tin fibril composed ofpFN and cFN, pFN and cFN are localized in discrete patches along the fibril.
Materials and Methods

Cell Culture and Labeling Conditions
Neonatal human foreskin fibroblasts were either grown in Ham's F-12 medium or Ham's F-12 and DME (1:1 ratio) supplemented with 10% FBS.
Fibroblasts used in immunofluorescent studies were plated at a density of 3 x 105 cells onto glass coverslips in 35-mm dishes and grown for either 18 or 42 h at 37°C. Cycloheximide (25 ~g/rnl) was added to some of the cultures after 1 h. FITC-pFN (20 ~g/ml or 250 t~g/ml) was appiied to some cultures 2 h after plating. In other experiments, fibroblasts were grown for 18 or 42 h, then washed and treated with cycloheximide (25/xg/ml) for 1 h. FITC-pFN was added to the cycloheximide-containing medium, and the cells were incubated for an additional 4 h.
For immunoelectron microscopy studies, fibroblasts were seeded onto formvar-coated gold grids on glass coverslips (Wolosewick and Porter, 1976) precoated with 160-180-kD cell attachment fragments of fibronectin (Williams et al., 1983; McKeown-Longo and Mosher, 1985) . Fibroblasts were allowed to attach for 3 h before the fibmblasts were treated with 25 /~g/ml cycloheximide for 18 h at 37°C. Some of the fibroblasts were then incubated with 20/zg/ml FITC-pFN for 3 h at 37°C.
Preparation of FITC-pFN and Colloidal Gold Antibody Complexes
Plasma fibronectin was purified as described by Mosher and Johnson (1983) . FITC-pFN was prepared using the procedure of McKeown-Longo and Mosher (1983) . Spectroscopy measurements at 280 and 495-nm indicated that the labeled protein contained '~3 FITC/subunit of fibronectin.
Colloidal gold beads 18 nm in diameter (Au18) were prepared by reducing gold chloride with trisodium citrate as described by Geoghegan and Ackerman (1977) . Colloidal gold beads 5 nm in diameter (Aus) were prepared by reducing gold chloride with white phosphorus as described by DeMay 0983).
Polyclonal antibodies to rabbit IgG and mouse IgG (Jackson Laboratory, Bar Harbor, ME) were coupled to Auls and Au5 beads, respectively, at pH 9.0 using the procedure described by DeMay (1983) . The minimal concentration of IgG necessary to stabilize l ml of the gold sol was determined using an absorption isotherm (Horisberger and Rosset, 1977) . Unbound areas on the gold beads were blocked with 1% BSA, pH 9.0.
Immunofluorescent Microscopy
Fibroblasts were washed three times with 10 mM sodium phosphate (pH 7.4) containing 150 mM sodium chloride and fixed for 30 min with 3.5% paraformaldehyde in 0.i M sodium phosphate (pH 7.4). Fixed cells were labeled for 30 min with either a monoclonal antibody (IST-9) to the EIIIA domain of cFN or a monoclonal antibody (IST-7) to an adjacent region of fibronectin (Borsi et al., 1987) . Ascites containing the antibodies was used at a dilution of 1:1,000 in 1% BSA in PBS. Cells were washed three times and then labeled with rhodamine-conjugated goat anti-mouse IgG in 1% ovalbumin in PBS for 45 rain.
lmmunoelectron High Voltage Electron Microscopy
Fibroblasts were washed three times with Hanks balanced salt solution (HBSS), prefixed with 0.1% glutaraldehyde, 0.1 M Hepes, pH 7.0, and treated with sodium borohydride (0.5 mg/ml), 0.1 M Hepes, pH 7.0, for 10 min. Prefixed fibroblasts were labeled with rabbit antifluorescein serum (1:100 dilution), and mouse IST-9 ascites (1:100 dilution). The labeling was for 1 h at 23°C in 20 mM Tris-HC1, pH 8.2, containing 150 mM sodium chloride, 20 mM sodium azide and 1% BSA. Cells were washed three times with the same buffer and then incubated for 1 h at room temperature with anti-rabbit IgG and anti-mouse IgG antibodies conjugated to Auls and Au5 gold beads, respectively, in the 20 mM Tris-HC1 (pH 8.2), 150 mM NaC1 buffer contains 20 mM sodium azide and 1% BSA. The fibroblasts were washed with 20 mM Tris-HC1 (pH 8.2), containing 150 mM sodium chloride and 20 mM sodium azide and prepared for electron microscopy as described previously (Peters and Mosher, 1987) . Figure 2. Deposition of endogenous FN in cells with a preexisting matrix of FITC-pFN. Cells were allowed to settle for 1 h and then treated with cycloheximide (25 #g/ml). After 1 h in cycloheximide, FITC-pFN (20 #g/ml) was added. The cells were incubated for 18 h, washed free of cycloheximide and FITC-pFN, placed in fresh medium, and incubated for an additional 3 h at 37°C to allow synthesis and deposition of cFN. Cells were fixed and labeled with IST-9 to cFN as described in 
Morphometric Analysis
Micrographs of extracellular matrix fibrils were randomly chosen from 25 different areas for each of the three experimental conditions analyzed. The distribution of 5-and 18-nm gold beads along the length of fibrils (2.0/~m) was determined by counting the number of gold beads found in consecutive 60-nm segments along the fibril. The length of each region along the fibril containing either cFN or pFN was determined using an IBM-XT computer and the Morphometer program (Woods Hole Educational Associates, Woods Hole, MA). The Sigmaplot program (Jandel Scientific, Corte Madera, CA) and Surfer Program (Golden Software, Golden, CO) were used to further analyze and graph the data.
Results
Double fluorescent microscopic studies of fibroblasts cultured for 18 or 42 h and then treated with cycloheximide and FITC-pFN showed that pFN does not necessarily bind to cFN on the cell surface (Fig. 1) . The lack of colocalization was more marked in cultures incubated with 250/~g/ml of FITC-pFN than with 20/~g/ml FITC-pFN. FITC-pFN was observed bound to the retracting edges of fibroblast surface along regions of the cell where very little cFN had previously been laid down (arrows). FITC-pFN was also observed bound to regions of the cell where cFN had previously been deposited (open arrows). Regions where only cFN existed were also observed (small arrowheads).
The converse experiment was done in which fibroblast cultures were grown for 18 h in cycloheximide in the presence of FITC-pFN followed by incubation in the absence of exogenous FITC-pFN and cycloheximide (Fig. 2, A-C) . I11 these cultures, FITC-pFN was found predominantly in linear arrangements. The newly synthesized cFN did not always colocalize with the FITC-pFN and appeared on the cell surface in arrays or patches (arrow).
A number of controls were done. If cells were incubated with FITC-pFN in the absence of cycloheximide, FITC-pFN and cFN colocalized at the fluorescent microscopic level with the exception of patches of cFN that were observed between the cells and coverslip. Under experimental conditions in which FITC-pFN did not colocalize with IST-9, FITCpFN did coiocalize with IST-7, a monoclonal antibody that does not distinguish between cFN and pFN.
Fibroblasts incubated with or without FITC-pFN (20/~g/ ml) in the presence or absence of cycloheximide were prepared by similar protocols and examined by high voltage electron microscopy. Fig. 3 A shows a fibroblast that had been grown for 24 h in the absence of cycloheximide and FITC-pFN and then labeled with IST-9 and anti-FITC. Cellular fibronectin (5-nm beads) is observed on the cell surface along stress fibers at the retracting end of the fibroblast and in fibrils in the extracellular space. Only an occasional 18-nm gold bead marking FITC-pFN is observed (also see Fig. 6 ). Presumably, this represents nonspecific binding of the anti-rabbit IgG-gold conjugate.
When FITC-pFN was added in the absence of cycloheximide, both cFN and FITC-pFN were observed distributed together in linear arrangements along the lateral and retracting edges of the fibroblast surface (Fig. 3 B) . However, there was not complete admixture of the two labels suggesting that the FITC-pFN was not binding to cFN on the cell surface (Fig. 3 C) .
When fibroblasts were incubated with FITC-pFN in the presence of cycioheximide and then labeled with anti-FITC and IST-9, FITC-pFN was observed bound to the cell surface in linear arrangements along the lateral and retracting edges of the fibroblast (Fig. 4 A) . The markers for cFN on the cell surface were reduced markedly compared to cells not incubated in cycloheximide. What little cFN was observed on the cell surface did not appear to coiocalize with FITC-pFN (Fig. 4 B) . Fibrils composed primarily of FITC-pFN were observed in the extracellular space (also see Fig. 6 ).
To verify the specificities of the labeling patterns, fibroblasts that had never been incubated with FITC-pFN and had been cultured in the presence of cycloheximide were labeled with anti-FITC and IST-9 antibodies. These cells did not show any labeling (Fig. 4 C) . Fibroblasts incubated without primary antibodies to FITC and cFN also showed no labeling (not shown).
The pattern of cFN and FITC-pFN in fibrils that contain both fibronectins was distinctive (Fig. 3 D) . FITC-pFN (arrows) and cFN (arrowheads) were grouped into discrete regions of the fibrils so that one area contained predominantly labels for cFN and an adjacent region contained labels for FITC-pFN. Several additional quantitative analyses were done on fibrils containing both cFN and FITC-pFN, fibrils containing mostly cFN, and fibrils containing mostly FITC-pFN. Fig. 6 , A-C, shows the average numbers of 5-and 18-nm gold beads found in consecutive 60-nm segments along the length of these three types of matrix fibrils. In fibrils grown in the absence of cycloheximide and FITC-pFN and therefore containing mostly cFN (Fig. 6 A) , only an occasional 18-nm gold bead (corresponding to FITC-pFN) was found. Likewise, in fibrils from cultures grown in the presence of cycloheximide and FITC-pFN and therefore containing mostly FITC-pFN, only an occasional 5-nm gold (corresponding to cFN) was found (Fig. 6 B) . When the average number of 5-and 18-nm beads were analyzed in fibrils containing both FITC-pFN and cFN, both labels are found throughout the length of the fibrils. The average numbers of the two labels in the three types of fibronectin fibrils are plotted against one another in Fig. 7 . The points are divided into three groups and do not overlap with one another.
Individual measurements from 60-nm segments along fibrils containing both cFN and FITC-pFN were plotted on a contour plot ( Fig. 8; compare to Fig. 7) . Few of the segments contained both 5-and 18-nm gold beads. Instead, individual segments contained mainly 5-or 18-nm gold beads, as was found in fibrils containing only cFN or FITC-pFN.
Discussion
The immunoelectron microscopy studies together with the fluorescence studies show that FITC-pFN is treated like cFN
The Journal of Cell Biology, Volume 11 I, 1990 by cultured fibroblasts. Both FITC-pFN and cFN were found bound to the cell surface along specific regions of the cell. These regions that occur primarily along the lateral and retracting edges of the fibroblast cell surface were shown previously to represent sites involved in the fibrillogenesis of fibronectin-gold complexes (Peters and Mosher, 1987) .
Our results support recent evidence (McKeown-Longo and Etzler, 1987; Allen-Hoffmann et al., 1988 ) that exogenous pFN can bind to the cell layer and become incorporated into the extracellular matrix of cells with blocked protein synthesis. This finding suggests that molecules on the cell surface involved in fibronectin binding and matrix assembly have a long half-life. It also demonstrates that pFN-cFN interactions are not needed for the binding of exogenous pFN to the cell surface. The immunoelectron microscopy studies further show that FITC-pFN was assembled into an extensive matrix within 3 h in the cycloheximide-treated cultures. Thus, pFN seems to contain all the structures needed for fibril assembly.
The deposition of pFN in the matrix of cultured fibroblasts has been shown to be dependent on the concentration of pFN used. Half maximal rates of incorporation (Km) are achieved at about 25 #g/ml (Allen-Hoffmann et al., 1988; Barry and Mosher, 1988) . The matrix itself contains binding sites for pFN which seem to be nonsaturable (Chernousov et al., 1985; Peters and Mosher, 1987) . By fluorescence microscopy of 18-or 48-h cultures pretreated with cycloheximide for 1 h and then incubated with FITC-pFN, the FITCpFN colocalized with preexisting fibrillar cFN and also appeared to form new fibrils not containing cFN. The new fibrils were detected more easily in cultures incubated with 250 #g/ml FITC-pFN (the plasma concentration but 10-fold higher than the estimated K., of incorporation) than in cultures incubated with 20 #g/ml FITC-pFN. This may be because the higher concentrations of FITC-pFN competed for or excluded the trace amounts of cFN secreted by cycloheximide-treated cells (estimated by immunoassay of medium to be ,05 % of nontreated cells). At the electron microscopic level, when cultures were treated with cycloheximide 3 h after plating, little cFN was found in fibrils of cycloheximidetreated cultures.
The deposition of bulk cFN in medium appears to follow the same rules as deposition of pFN (Allio and McKeownLongo, 1988 ). There appeared, however, to be regions of the ventral cell surface where cFN was deposited preferentially. We speculate that cFN may be vectoriaily secreted to regions of the cell surface able to assemble fibronectin or into restricted volumes in which cFN is preferentially assembled.
Our most intriguing finding is that when FITC-pFN and cFN coassemble into fibrils, the fibrils have regions enriched in one of the two forms. This finding could be due to vectorially or temporally regulated secretion; e.g., pulses of cFN secretion into assembly sites. We favor, however, the explanation that the orientation of fibronectin in fibrils may impose certain structural requirements that encourage cFN to bind preferentially to cFN and pFN to bind to pFN. As shown in Fig. 9 , subunits containing EIIIA and/or EIIIB may preferentially interact with one another leading to an area . FITC-pFN (large gold beads) and cFN (small gold beads) are grouped in discrete patches along the fibril. Arrowheads denote areas where discrete patches are not apparent. Bar, 0.16 #m. When data from 25 randomly chosen fibrils were analyzed, it was found that the patches of cFN and FITC-pFN varied in length from 9 to 812 nm for cFN and 28 to 1,200 nm for FITC-pFN. The average lengths of these patches were 152 nm for cFN and 172 nm for FITCpFN. There are regions where no label is observed. This is presumably due to the fact that the IST-9 antibody recognizes only cFN molecules that have EIIIA inserts. Fig. 7, closed circles) . Measurements from 25 randomly chosen fibrils were plotted, N = 876. The number 4 represents the frequency with which data points are observed along that contour line.
that is enriched in cFN and poor in FITC-pFN. Conversely, FITC-pFN may assemble with itself unless it encounters a heterodimeric cFN consisting of one subunit with the EIIIA/B sequences and a second subunit lacking the EIIIA/B sequences. Such preferential binding and assembly would insure that cells induced to secrete certain isoforms of fibronectin, as happens with growth factor stimulation (Baiza et al., 1988) or during embryogenesis (ffrench-Constant and Hynes, 1988) and wound healing (ffrench-Constant et al., 1989) , are able to populate their matrix with the secreted isoforms despite the presence of other isoforms of fibronectin.
The data presented in this manuscript do not enable us to predict the exact interactions between neighboring fibronectin molecules. Fig. 9 assumes a simple head-to-tail interaction of subunits. Further studies need to be done to determine the three-dimensional structure of fibronectincontaining fibrils and the exact sites of polymerization. 
